Product Information
CLOZAPINE 50 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.5418 per EA under NDC 60687054801. Its NADAC has been published 316 times since Sep 16, 2020.
FDA first approved this application on Nov 29, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
American Health PackagingNDC
60687054801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLOZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA206433FDA Approved
11/29/2016
TE Code
AB
On Market Since
7/7/2020
Pharmacological Classes
Price Statistics
The NADAC for CLOZAPINE 50 MG TABLET has been published 316 times since Sep 16, 2020, and over the history we have for it it has declined 10.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5418 per EA |
|---|---|
| All-time high | $0.6698 (Feb 10, 2021) |
| All-time low | $0.4113 (Nov 22, 2023) |
| 52-week high | $0.5461 |
| 52-week low | $0.4791 |
| Median price | $0.5228 |
| Average price | $0.5228 |
| Largest weekly change | +36.8% (Dec 20, 2023) |
| Weeks tracked | 316 |
| Tracking since | Sep 16, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Clozapine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
American Health Packaging manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clozapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOZAPINE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOZAPINE 50 MG TABLET, manufactured by American Health Packaging, is $0.5418 per EA (NDC 60687054801), effective Sep 30, 2026.
How has the price of CLOZAPINE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOZAPINE 50 MG TABLET has declined 10.4%. It has been tracked across 316 weekly CMS publications since Sep 16, 2020.
What are the highest and lowest recorded NADAC prices for CLOZAPINE 50 MG TABLET?
Since Sep 16, 2020, the NADAC for CLOZAPINE 50 MG TABLET has ranged from a low of $0.4113 (Nov 22, 2023) to a high of $0.6698 (Feb 10, 2021), with a median of $0.5228 per EA.
Are there cheaper alternatives to CLOZAPINE 50 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CLOZAPINE 50 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLOZAPINE 50 MG TABLET?
CLOZAPINE 50 MG TABLET (NDC 60687054801) is labeled by American Health Packaging, and CMS classifies it as a generic product.